Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
about
Contrast Enhanced MRI in the Diagnosis of HCCAdvances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaRecent Advances in Tumor Ablation for Hepatocellular CarcinomaClinical utility of imaging for evaluation of hepatocellular carcinomaRole of Organic Anion-Transporting Polypeptides (OATPs) in Cancer TherapyRadiological diagnosis of hepatocellular carcinomaDiagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current ConsensusFocal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRIRecent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRILiver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlationLiver masses: a clinical, radiologic, and pathologic perspective.Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoringNew paradigm for management of hepatocellular carcinoma by imaging.Physiologically realistic and validated mathematical liver model reveals [corrected] hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data.Quantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.Chemically induced mouse liver tumors are resistant to treatment with atorvastatin.MRI features of hepatocellular carcinoma related to biologic behaviorThe expression and function of organic anion transporting polypeptides in normal tissues and in cancerMolecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.Inter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA)Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI.Threshold doses and prediction of visually apparent liver dysfunction after stereotactic body radiation therapy in cirrhotic and normal livers using magnetic resonance imaging.Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions.Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers.Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT).Bile acids activate YAP to promote liver carcinogenesis.Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations.Hepatocellular nodules in liver cirrhosis: MR evaluation.Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.Imaging of HCC.Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?
P2860
Q26768472-81AD0DDC-0161-458E-A419-618ABF8D6FD4Q26772334-CEA0F104-05F2-4E8E-BE60-C56909E91EF0Q26775418-065EC83F-B902-4AA1-9DD9-071B77D582F1Q26823224-9AA8443B-E927-4A79-8773-834524337C8DQ26829894-43D2B5FE-191F-4759-B72E-39B6DFC718A3Q27027683-93EB4B8B-7279-4032-912E-5AE449C3B099Q27027855-CCEA96B9-0396-4C65-A0BD-A1A591546C5FQ27028207-FA92708E-EBEF-4B9A-8928-4FCE556490E2Q28075361-425FBBEF-7968-449B-8C8C-0E9B87C0BECAQ30359290-269033F0-8D66-4E32-8BC5-CCBECE29E2CAQ30403670-2FB06173-AA21-418C-B779-72D785843BA6Q30436747-40230A24-6467-4FEA-B12F-46445AB832D6Q30448048-94E76D52-BF53-4EDF-9011-2579D1E4672FQ30804696-2BDF0DD3-F8BC-4044-95FE-19626DEBCFA9Q33561380-F856B875-4995-453F-9865-4230773FD9B8Q34681076-0CEB3BE3-E0B8-40C2-8489-BCE21FAAE7ECQ35207733-B0BF754A-1301-465C-A86B-45981AD726AFQ35335391-3B2273EC-29C8-4757-8992-554609C3D779Q35619951-96CCE693-CD35-4481-982B-2E8E98BBD1C0Q35670179-D2572650-E2BA-4529-A16C-730A7D9A5F69Q35768413-5B81E874-D0A1-43B9-A2A2-4AC48B6AAD38Q35909487-D71734C4-DB98-49AC-BB90-26B3CC4FFEC3Q36236573-CA3B2DB7-7C53-4F4A-92BD-890058B8C7C0Q36325824-5561AEEA-A2AD-44F3-891F-CECD405472E5Q36326113-CAA28ABD-E875-44E5-8B2E-E1B15731A448Q36542919-5783AC51-35A9-42A8-B16A-8BD581AA2794Q36902478-682AC795-6D12-4549-9FBF-344640F708A0Q37025536-9308EE9C-8EBB-453C-839D-4DD077C3540CQ37120923-C8D21BBF-545E-4209-8CC0-713191E6DE74Q37175669-55C40EFA-661B-40B9-B910-FF5FB257AA65Q37487034-406F7DB2-CA73-4154-845D-A1490EB840F9Q37488806-C8D97B95-356C-4DD6-BBAC-619A3B1D6671Q37582508-71B8785B-2C99-46A9-92AD-C975D6395788Q37635549-2B913A72-6DF9-4743-BA2E-14E3200C29BFQ37651886-8E308A6F-4775-4D0D-AD8C-A4300A54DCEEQ37708229-FB49291F-DEEE-4B33-A3E7-56AA78BB912AQ37852598-4831F07A-47AA-4096-A383-A5B4554BDEB5Q37924180-4AEEBB11-C230-44B1-8F14-A8B085A2CD4BQ37930465-5CD43C39-02A6-463E-898F-D121B6195AEEQ37950331-73947C8E-60F7-48D7-B91B-3C015E8C0B6D
P2860
Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocellular carcinoma: hepa ...... porters and bile accumulation.
@en
Hepatocellular carcinoma: hepa ...... porters and bile accumulation.
@nl
type
label
Hepatocellular carcinoma: hepa ...... porters and bile accumulation.
@en
Hepatocellular carcinoma: hepa ...... porters and bile accumulation.
@nl
prefLabel
Hepatocellular carcinoma: hepa ...... porters and bile accumulation.
@en
Hepatocellular carcinoma: hepa ...... porters and bile accumulation.
@nl
P2093
P356
P1433
P1476
Hepatocellular carcinoma: hepa ...... porters and bile accumulation.
@en
P2093
Atsushi Nakamoto
Hiroaki Nagano
Hirofumi Akita
Hiromitsu Onishi
Kaname Tomoda
Kenichi Wakasa
Masatoshi Hori
Mitsuaki Tatsumi
Nariaki Matsuura
Takahiro Tsuboyama
P304
P356
10.1148/RADIOL.10091557
P407
P577
2010-06-01T00:00:00Z